Drugmaker Squibb Settles Antitrust Cases Bristol-Myers Squibb agrees to pay $670 million to settle several lawsuits. The suits accused the pharmaceutical company of fraudulently restricting competitors from selling cheap copies of two of its best-selling drugs. NPR's Snigdha Prakash reports.

Drugmaker Squibb Settles Antitrust Cases

Drugmaker Squibb Settles Antitrust Cases

  • Download
  • <iframe src="https://www.npr.org/player/embed/907889/907890" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Bristol-Myers Squibb agrees to pay $670 million to settle several lawsuits. The suits accused the pharmaceutical company of fraudulently restricting competitors from selling cheap copies of two of its best-selling drugs. NPR's Snigdha Prakash reports.